Fisher & Paykel Healthcare Corporation Limited today announced it will hold an Investor Event on Thursday, 14 September and Friday, 15 September 2023 in Tijuana, Mexico and Irvine, California. The Investor Event will provide the opportunity for investors and analysts to visit our operations in Tijuana, Mexico and Irvine, California and meet leaders from our Mexico and US teams. The Investor Event is in-person only.
Please register at the following site: http://www.fphcare.com/investor-day/.
About Fisher & Paykel Healthcare
Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Media & Investor Contacts:
Head of Capital Markets & Investor Relations
+64 (0) 27 807 8073
Senior Communications and Investor Relations Manager
+64 (0) 22 511 4050
Fisher & Paykel Healthcare announces 2023 US / Mexico Investor Event
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment